Johnson & Johnson Cv Rx, Inc. Transaction History
Johnson & Johnson
- $297 Million
- Q2 2025
A detailed history of Johnson & Johnson transactions in Cv Rx, Inc. stock. As of the latest transaction made, Johnson & Johnson holds 4,103,430 shares of CVRX stock, worth $28.4 Million. This represents 8.12% of its overall portfolio holdings.
Number of Shares
4,103,430
Previous 4,103,430
-0.0%
Holding current value
$28.4 Million
Previous $50.2 Million
51.92%
% of portfolio
8.12%
Previous 16.67%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
94Shares Held
14.9MCall Options Held
42.2KPut Options Held
32.4K-
Nea Management Company, LLC Timonium, MD2.03MShares$14 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$7.44 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$6.05 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT789KShares$5.45 Million0.62% of portfolio
-
Balyasny Asset Management LLC Chicago, IL675KShares$4.66 Million0.01% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $142M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...